MEMarziyeh Etesami

Marziyeh Etesami

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marziyeh Etesami has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Beyond the stomach: Exploring the role of Helicobacter pylori in pushing precancerous lesions to colorectal cancer and the therapeutic potential of probiotics

    by Zahra Sadeghloo, Mehdi Azizmohammad Looha, Marziyeh Etesami, Georg Conrads, Sama Rezasoltani, Amir Sadeghi, Ehsan Nazemalhosseini Mojarad

    Colorectal cancer (CRC), a major global health burden, is the second leading cause of cancer deaths. This review examines the link between Helicobacter pylori infection and CRC, highlighting its role beyond gastric pathology. Affecting over half the world’s population, H. pylori is associated with increased CRC risk through direct and indirect mechanisms. Direct pathways include toxins like CagA and VacA, which drive inflammation, and hypergastrinaemia, which promotes colorectal cell proliferation. Indirectly, H. pylori induces immune dysregulation, shifts to immune-evasive coccoid forms, survives intracellularly, releases oncogenic vesicles, disrupts autophagy, alters non-coding RNAs by dysregulating their expression profiles and contributes to gut microbiota dysbiosis. Additionally, we discuss the potential of probiotic interventions to counteract H. pylori ’s pathogenic effects by restoring gut microbial balance, reducing inflammation and modulating immunity by regulating cytokine and T-cell profiles. Future research should translate these molecular insights into clinical applications, including evaluating whether H. pylori eradication reduces CRC risk in high-risk populations and assessing the preventive potential of specific probiotic strains in controlled human trials.

  • Open Access

    Investigating the expression of CTLA-4 and CD28 genes as immune regulators in patients with colorectal polyps

    by Marziyeh Etesami, Flora Forouzesh, Amirreza Hooshmand, Mahsa Saeedi Niasar, Pardis Ketabi Moghadam, Ehsan Nazemalhosseini-Mojarad

  • Open Access

    Identification of Critical miRNAs miR ‐4652 and miR ‐1304 as Novel Diagnostic Markers for Oral Squamous Cell Carcinoma

    by Sara Bagheri Farahani, Ehsan Keramati, Marziyeh Etesami, Faranak Jamshidian

    Background: Oral squamous cell carcinoma (OSCC) is marked by frequent recurrence rates and an unclear etiology, underscoring the critical need for early detection to improve therapeutic outcomes and reduce healthcare costs. MicroRNAs (miRNAs) have emerged as key regulators of oral carcinogenesis by modulating gene expression at the posttranscriptional level and influencing various aspects of cellular physiology. Objective: This study aimed to comprehensively evaluate the prognostic significance of miR‐1304 and miR‐4652 expression levels in patients with OSCC, and to explore their potential as predictive biomarkers for disease progression and patient survival. Methods: TargetScan was used to predict potential gene interactions of the microRNAs. Subsequently, the expression levels of C‐Myc and the microRNAs miR‐1304‐3p and miR‐4652‐5p were evaluated in 30 pairs of OSCC and adjacent normal tissue samples. qRT‐PCR analyses were performed to compare the expression of these molecules between tumor and normal tissues. Additionally, receiver operating characteristic (ROC) curves were generated to assess the potential diagnostic value of these microRNAs in OSCC. Result: The expression levels of miR‐1304, miR‐4652, and C‐Myc were significantly higher in OSCC tissues compared to their matched adjacent non‐tumor tissues ( p < 0.0001). Notably, high C‐Myc expression was significantly correlated with both tumor grade ( p = 0.003) and tumor stage ( p = 0.005). ROC curve analysis demonstrated that the areas under the curve (AUCs) for C‐Myc, hsa‐miR‐1304, and hsa‐miR‐4652 were 0.99, 0.99, and 0.95, respectively ( p < 0.0001), indicating strong diagnostic potential. Conclusion: These findings suggest that the upregulation of miR‐1304 and miR‐4652 could be used as biomarkers in OSCC. However, more studies with large samples are necessary.